Get the Stockscreener App
3.26
2.40%
-0.08
Biomerica Inc stock is traded at $3.26, with a volume of 6,206.
It is down -2.40% in the last 24 hours and down -10.44% over the past month.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
See More
Previous Close:
$3.34
Open:
$3.365
24h Volume:
6,206
Relative Volume:
0.19
Market Cap:
$8.73M
Revenue:
$5.51M
Net Income/Loss:
$-6.16M
P/E Ratio:
-8.8108
EPS:
-0.37
Net Cash Flow:
$-5.03M
1W Performance:
-4.96%
1M Performance:
-10.44%
6M Performance:
+29.37%
1Y Performance:
-30.93%
1-Day Range:
$3.25
$3.4383
1-Week Range:
$3.13
$3.60
52-Week Range:
$1.932
$10.16
Biomerica Inc Stock (BMRA) Company Profile
Name
Biomerica Inc
Sector
Industry
Phone
(949) 379-2875
Address
17571 VON KARMAN AVENUE, IRVINE, CA
Compare BMRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BMRA
Biomerica Inc
|
3.26 | 8.73M | 5.51M | -6.16M | -5.03M | -0.37 |
|
ABT
Abbott Laboratories
|
132.28 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
SYK
Stryker Corp
|
373.37 | 147.15B | 23.22B | 2.86B | 3.58B | 7.40 |
|
BSX
Boston Scientific Corp
|
101.73 | 146.97B | 17.55B | 2.03B | 2.72B | 1.37 |
|
MDT
Medtronic Plc
|
86.17 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
73.27 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Biomerica Inc Stock (BMRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-10-20 | Initiated | Colliers Securities | Buy |
| Jan-04-18 | Initiated | B. Riley FBR, Inc. | Buy |
Biomerica Inc Stock (BMRA) Latest News
Biomerica (NASDAQ:BMRA) Stock Price Passes Below 200 Day Moving Average – What’s Next? - Defense World
Biomerica appoints Eric B. Chin to Board of Directors By Investing.com - Investing.com South Africa
Biomerica, Inc. Announces Board and Committee Changes, Effective June 4, 2025 - marketscreener.com
Biomerica appoints Eric B. Chin to Board of Directors - Investing.com Australia
Biomerica Appoints Eric B. Chin to Board - TipRanks
Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair | BMRA Stock News - GuruFocus
Healthcare CFO Who Raised $60M Joins Biomerica Board to Lead Audit Committee - Stock Titan
Biomerica's inFoods IBS Clinical Study Results Published in June 2025 Issue of Gastroenterology - marketscreener.com
inFoods IBS test shows promise for IBS management - Investing.com
Biomerica (BMRA) Showcases Promising Results for inFoods IBS Tes - GuruFocus
Biomerica announces publication of data from inFoods IBS clinical study - TipRanks
Biomerica's inFoods® IBS Clinical Study Results Published in Jun - GuruFocus
Biomerica (BMRA) Showcases Promising Results for inFoods IBS Test in Clinical Trial | BMRA Stock News - GuruFocus
Biomerica's inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology - The Manila Times
Biomerica's inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology | BMRA Stock News - GuruFocus
Breakthrough IBS Treatment Shows 60% Success Rate in Major Clinical Trial, Published in Gastroenterology - Stock Titan
Biomerica announces real-world results of its inFoods IBS product - TipRanks
Biomerica (BMRA) Reports Positive Real-World Results for inFoods - GuruFocus
Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback System | BMRA Stock News - GuruFocus
Wall Street Backs Dell’s AI Strategy with Buy Ratings - The Globe and Mail
New IBS Treatment Cuts Pain by 49% Without Drugs: Groundbreaking Real-Time Patient Monitoring System Launches - Stock Titan
‘AI Momentum Is Real,’ Say Analysts After Google I/O 2025 - The Globe and Mail
Glass House Brands and LEEF Announce MSA for The Leaf El Paseo Dispensary and Off-Take Agreement - The Globe and Mail
Prediction: This Artificial Intelligence (AI) Semiconductor Stock Will Soar After May 28 - The Globe and Mail
Biomerica, Inc. and CLIA Laboratory Partner Filed for inFoods IBS Test - marketscreener.com
Biomerica submits application for PLA code for inFoods IBS diagnostic test - TipRanks
Biomerica (BMRA) Seeks New CPT Code for IBS Diagnostic Test | BMRA Stock News - GuruFocus
PLA Code Application Filed for inFoods IBS TestA Key Step Toward Reimbursement - The Manila Times
PLA Code Application Filed for inFoods IBS Test -- A Key Step Toward Reimbursement | BMRA Stock News - GuruFocus
PLA Code Application Filed for inFoods IBS Test — A Key Step Toward Reimbursement - TradingView
Biomerica Stock Slumps After Reverse Stock Split Announcement: Retail’s Disappointed - MSN
Biomerica (NASDAQ:BMRA) Stock Price Crosses Below Two Hundred Day Moving Average – Time to Sell? - American Banking and Market News
Biomerica announces Fortel Ulcer Test approved for sale by UAE Ministry - TipRanks
Biomerica (BMRA) Gains UAE Approval for Fortel Ulcer Test | BMRA Stock News - GuruFocus
United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Detection of H. pylori Infection - The Manila Times
United Arab Emirates Ministry of Health and Prevention Approves - GuruFocus
BMRA Stock Might Surge: Biomerica’s New Ulcer Test Now Available Across the UAE - Own Snap
United Arab Emirates Ministry Of Health And Prevention Approves Biomerica'S Fortel® Ulcer Test For Detection Of H. Pylori Infection - marketscreener.com
Biomerica Secures Major UAE Approval for Rapid H. Pylori Test as Middle East Expansion Accelerates - Stock Titan
BMRA stock touches 52-week high of $3.84 amid market fluctuations - Investing.com
Financial Health Report: Biomerica Inc (BMRA)’s Ratios Tell a Tale - DWinneX
BMRA stock touches 52-week high of $3.84 amid market fluctuations By Investing.com - Investing.com South Africa
Biomerica’s kidney disease test gains approval for sale in UAE - Yahoo Finance
Biomerica stock plummets on 1-for-8 reverse stock split - MSN
Biomerica’s kidney disease test approved for UAE market By Investing.com - Investing.com Canada
Walmart to Expand Sales of BiomericaÆS Aware Breast Self Exam; Product Will Now Be Available in over 2400 Walmart Stores - marketscreener.com
Biomerica (BMRA) Gains UAE Approval for Fortel Kidney Disease Te - GuruFocus
BiomericaFortel Kidney Disease Test Approved For Sale In UAE - marketscreener.com
Biomerica’s kidney disease test approved for UAE market - Investing.com Australia
United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Disease Test for Early Detection of Kidney Damage - The Manila Times
Revolutionary 10-Minute Test Could Help Detect Hidden Kidney Disease in 80% of At-Risk Patients - Stock Titan
Biomerica Inc Stock (BMRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):